These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27136318)

  • 21. Prediction of tumour response induced by chemotherapy using modelling of CA-125 kinetics in recurrent ovarian cancer patients.
    Wilbaux M; Hénin E; Oza A; Colomban O; Pujade-Lauraine E; Freyer G; Tod M; You B
    Br J Cancer; 2014 Mar; 110(6):1517-24. PubMed ID: 24556626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of platinum-sensitive recurrent ovarian cancer.
    Pfisterer J; Ledermann JA
    Semin Oncol; 2006 Apr; 33(2 Suppl 6):S12-6. PubMed ID: 16716798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved survival with single-agent paclitaxel consolidation/maintenance therapy in advanced ovarian carcinoma.
    Micha JP; Goldstein BH; Graham C; Rettenmaier MA; Brown JV; Hu JC; Markman M
    Oncology; 2006; 71(1-2):49-53. PubMed ID: 17377414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gemcitabine in epithelial ovarian cancer treatment: current role and future perspectives.
    Lorusso D; Ferrandina G; Fruscella E; Marini L; Adamo V; Scambia G
    Int J Gynecol Cancer; 2005; 15(6):1002-13. PubMed ID: 16343176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study.
    Olawaiye AB; Java JJ; Krivak TC; Friedlander M; Mutch DG; Glaser G; Geller M; O'Malley DM; Wenham RM; Lee RB; Bodurka DC; Herzog TJ; Bookman MA
    Gynecol Oncol; 2018 Oct; 151(1):18-23. PubMed ID: 30135020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gemcitabine plus carboplatin in platinum-sensitive recurrent ovarian carcinoma.
    Kose MF; Meydanli MM; Tulunay G
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):437-43. PubMed ID: 16503860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG.
    Pfisterer J; Plante M; Vergote I; du Bois A; Hirte H; Lacave AJ; Wagner U; Stähle A; Stuart G; Kimmig R; Olbricht S; Le T; Emerich J; Kuhn W; Bentley J; Jackisch C; Lück HJ; Rochon J; Zimmermann AH; Eisenhauer E; ; ;
    J Clin Oncol; 2006 Oct; 24(29):4699-707. PubMed ID: 16966687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trial of combination nab-paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma.
    Alva A; Daignault S; Smith DC; Hussain M
    Invest New Drugs; 2014 Feb; 32(1):188-94. PubMed ID: 24318901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase II clinical trial of topotecan and carboplatin in patients with newly diagnosed advanced epithelial ovarian cancer.
    Vecchione F; Fruscio R; Dell'Anna T; Garbi A; Garcia Parra R; Corso S; Lissoni AA
    Int J Gynecol Cancer; 2007; 17(2):367-72. PubMed ID: 17362314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer.
    Friedlander M; Buck M; Wyld D; Findlay M; Fitzharris B; De Souza P; Davies T; Kalimi G; Allan S; Perez D; Harnett P
    Int J Gynecol Cancer; 2007; 17(2):350-8. PubMed ID: 17362312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experience with gemcitabine-carboplatin chemotherapy in relapsed ovarian cancer].
    Lehoczky O; Pulay T
    Orv Hetil; 2006 Jul; 147(30):1405-8. PubMed ID: 16977778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gemcitabine for unresectable, locally advanced or metastatic bladder cancer.
    Shelley M; Cleves A; Wilt TJ; Mason M
    Cochrane Database Syst Rev; 2011 Apr; (4):CD008976. PubMed ID: 21491413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gemcitabine plus paclitaxel versus carboplatin plus either gemcitabine or paclitaxel in advanced non-small-cell lung cancer: a literature-based meta-analysis.
    Li C; Sun Y; Pan Y; Wang Q; Yang S; Chen H
    Lung; 2010 Oct; 188(5):359-64. PubMed ID: 20703493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for advanced recurrent or refractory ovarian cancer: a systematic review and economic evaluation.
    Edwards SJ; Barton S; Thurgar E; Trevor N
    Health Technol Assess; 2015 Jan; 19(7):1-480. PubMed ID: 25626481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study).
    Fujiwara H; Ushijima K; Nagao S; Takei Y; Shimada M; Takano M; Yoshino K; Kawano Y; Hirashima Y; Nagase S; Nishio S; Nishikawa T; Ito K; Shoji T; Kimura E; Takano T; Sugiyama T; Kigawa J; Fujiwara K; Suzuki M
    Int J Clin Oncol; 2019 Oct; 24(10):1284-1291. PubMed ID: 31127479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Phase II, randomized, double-blind study of zibotentan (ZD4054) in combination with carboplatin/paclitaxel versus placebo in combination with carboplatin/paclitaxel in patients with advanced ovarian cancer sensitive to platinum-based chemotherapy (AGO-OVAR 2.14).
    Cognetti F; Bagnato A; Colombo N; Savarese A; Scambia G; Sehouli J; Wimberger P; Sorio R; Harter P; Mari E; McIntosh S; Nathan F; Pemberton K; Baumann K
    Gynecol Oncol; 2013 Jul; 130(1):31-7. PubMed ID: 23234805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gemcitabine and carboplatin in second-line ovarian cancer.
    Ozols RF
    Semin Oncol; 2005 Aug; 32(4 Suppl 6):S4-8. PubMed ID: 16143161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overcoming drug resistance in ovarian carcinoma.
    Fracasso PM
    Curr Oncol Rep; 2001 Jan; 3(1):19-26. PubMed ID: 11123865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
    Argiris A; Liptay M; LaCombe M; Marymont M; Kies MS; Sundaresan S; Masters G
    Lung Cancer; 2004 Aug; 45(2):243-53. PubMed ID: 15246197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy.
    Sehouli J; Stengel D; Oskay G; Camara O; Hindenburg HJ; Klare P; Blohmer J; Heinrich G; Elling D; Ledwon P; Lichtenegger W;
    Ann Oncol; 2002 Nov; 13(11):1749-55. PubMed ID: 12419747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.